IMRN - (Immuron Limited)

 IMRNのチャート


 IMRNの企業情報

symbol IMRN
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種   
概要 事業概要 --     Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States. The HyperImmune Products segment comprises of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear 2017年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/imrn
adr_tso 345878
EBITDA EBITDA ー
終値(lastsale) 8.183
時価総額(marketcap) 2830319.674
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 IMRNのテクニカル分析


 IMRNのニュース

   Immuron Partners with CSIRO to produce a new oral therapeutic for clinical evaluation by the US Department of Defense  2020/06/19 10:00:00 GlobeNewswire
Key Points Immuron executes a Research Agreement with The Henry M. Jackson Foundation for Advancement of Military Medicine Inc.Immuron executes a…
   The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset  2020/06/10 11:30:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Imara Inc (NASDAQ: IMRA ) IMMURON LTD/S ADR (NASDAQ: IMRN )( reacted to an award of a $3.7 million in DoD funding for a new candidate that offers protection against travelers' diarrhea) Inari Medical Inc (NASDAQ: NARI ) Keros Therapeutics Inc (NASDAQ: KROS ) Neoleukin Therapeutics Inc (NASDAQ: NLTX ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) United Therapeutics Corporation (NASDAQ: UTHR ) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows June 9) Applied Molecular Transport Inc (NASDAQ: AMTI ) (IPOed Friday) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Stocks In Focus Melinta Agrees To Take Tetraphase Private For $39M In Cash And $16M In CVRs With the two-way contest for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) ending after AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) pulled out, Melinta announced a definitive merger agreement to acquire Tetraphase, through a tender offer, for an aggregate of $39 million in cash, plus an additional $16 million in cash potentially payable under contingent value rights to be issued in the proposed acquisition.
   Can the 800% Gain in Immuron Be Rationalized Very Easily?  2020/06/09 23:16:44 24/7 Wall street
   Immuron's stock blasts off nearly 10-fold after partner NMRC seeks pre-IND meeting with FDA  2020/06/09 19:02:43 MarketWatch
The U.S.-listed shares of of Immuron Ltd. undefined skyrocketed nearly 10-fold on massive volume in afternoon trading Tuesday, after the Australia-based…
   The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down  2020/03/25 11:29:21 Benzinga Feeds
Here's a roundup of top developments in the … Full story available on Benzinga.com
   The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down  2020/03/25 11:29:21 Benzinga Feeds
Here's a roundup of top developments in the … Full story available on Benzinga.com
   The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down  2020/03/25 11:29:21 Benzinga Feeds
Here's a roundup of top developments in the … Full story available on Benzinga.com

 関連キーワード  (― 米国株 IMRN Immuron Limited)

 twitter  (公式ツイッターやCEOツイッターなど)